MEDIOS AG Medios AG: Bryan, Garnier & Co initiates coverage of Medios with 'Buy' recommendation and price target of €65.00
Transparency directive : regulatory news
|
DGAP-News: Medios AG
/ Key word(s): Study/Research Update
Press Release Berlin, February 11, 2022 - Bryan, Garnier & Co today initiated coverage of Medios AG and issued a "Buy" recommendation on the shares of the leading provider of Specialty Pharma solutions in Germany. Accordingly, the price target amounts to €65.00 per share. The Medios share price currently stands at €29.45 (Xetra closing on February 10, 2022). In addition to Bryan, Garnier & Co, Medios continues to be covered by Berenberg, Deutsche Bank, Jefferies, Kepler Cheuvreux, Metzler Capital Markets and Warburg. ------------------- About Medios AG Medios AG is the leading provider of Specialty Pharma solutions in Germany. As a competence partner and expert, Medios covers all relevant aspects of the supply chain in this field: from pharmaceutical supply to the manufacture of patient-specific therapies including blistering. The focus is on optimal patient care via specialized pharmacies. Medios AG is Germany's first listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8) are listed on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard). www.medios.ag Nikolaus Hammerschmidt Disclaimer
11.02.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | Medios AG |
| Heidestraße 9 | |
| 10557 Berlin | |
| Germany | |
| Phone: | +49 30 232 566 - 800 |
| Fax: | +49 30 232 566 - 801 |
| E-mail: | ir@medios.ag |
| Internet: | www.medios.ag |
| ISIN: | DE000A1MMCC8 |
| WKN: | A1MMCC |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1279764 |
| End of News | DGAP News Service |
|
|
1279764 11.02.2022